ftInvstr
HALEOSLABS · Healthcare ₹1443.0 -2.17% Mkt Cap ₹439 Cr
← Search another stock

HALEOSLABS

Healthcare Biotechnology
★ Watchlist ⧉ Add to bucket
₹1443.0
-2.17% today · 30d +1.55%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for HALEOSLABS. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹73 Cr
-11.59% YoY
NET PROFIT
₹2 Cr
-58.0% YoY
OPM
13.06%
-2.17pp YoY
EPS
₹8.75
PE 27.98
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-4.7% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
HALEOSLABS27.9812.0
BIOCON154.516.88
ANTHEM91.3531.1
ONESOURCE—5.79
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
56
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 90
Valuation REASONABLE 60
Growth MUTED 34
Profitability DECENT 58
Technicals WEAK 45
Risk MODERATE 50
Key Stats
TTM PE
27.98
P/B
2.07
52W HIGH
₹1774.0
OFF HIGH
-18.66%
DIV YIELD
0.1%
MKT CAP
₹439 Cr
◉ Active Signals
MACDBearish-0.7081
RSI(14)Neutral42.33
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold HALEOSLABS and at what entry.

Sign up freeSign in
AI-generated research based on publicly available data and ftInvstr's bias-safe quantitative models. Not investment advice. Past performance does not guarantee future results. Consult a SEBI-registered investment adviser before making any investment decision.